| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is leading significant advancements in product development, particularly in the healthcare and obesity treatment sectors. The company's innovative GLP-1 drugs show remarkable efficacy in weight loss, supported by successful clinical trials that enhance their market viability. This progress reflects positively on Eli Lilly's research capabilities and aligns with the growing demand for effective weight loss options. The emphasis on community development and engagement also plays a role in their broader impact and outreach. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 2.1 is extremely bullish. The market sentiment at 0.4 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.8, and the negative at -0.4 on 2026-05-21. The forces of Stock Price Trend (2.1), Sentiment towards Fundamentals (1.6), Option Sentiment (0.8), and Sector Price Trend (0.7) will drive up the price. The forces of Valuation Sentiment (-0.1), Price Level Sentiment (-0.5), and Market Risk Appetite (-1.8) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 1%(0.1%) | 1041.9 | 5.19% | 86 | 2.33% | 0.67% | 2.1 | 0.6 | 1.2% | 0.4 | Long | 65% | 1.6 | 6.8 |
| 2026-05-20 | 0%(0%) | 1018.14 | 5.11% | 79 | -0.3% | 0.31% | 0.9 | 0.3 | 1.3% | 0.2 | Long | 55% | 0.7 | -0.5 |
| 2026-05-19 | 0%(0%) | 1021.22 | 4.97% | 83 | 3.34% | 0.33% | 1.5 | 0.6 | 1.2% | 0.4 | Long | 65% | 2.5 | 5.5 |
| 2026-05-18 | 0%(0%) | 988.2 | 5% | 70 | -1.64% | 0.2% | 1 | -0.1 | 1% | 0.6 | Wait | 50% | 2.4 | -8 |
| 2026-05-17 | 0%(0%) | 1.9 | -0.1 | 0.8 | 2.6 | -1 | ||||||||
| 2026-05-16 | 0%(0%) | 1.9 | -0.1 | 0.7 | 2.5 | -1 | ||||||||
| 2026-05-15 | 0%(0%) | 1004.66 | 4.86% | 81 | -0.34% | 0.42% | 1.9 | -0.1 | 0.6% | 0.8 | Long | 65% | 2.1 | -1 |
| 2026-05-14 | 0%(0%) | 1008.04 | 4.66% | 86 | -0.78% | 0.75% | 2.1 | 0.1 | 0.9% | 0.9 | Long | 65% | 1.9 | 4 |
| 2026-05-13 | 0%(0%) | 1015.93 | 4.42% | 95 | 2.63% | 1.72% | 2.9 | 0.7 | 1.7% | 1.1 | Long | 70% | 2.2 | -1 |
| 2026-05-12 | 0%(0%) | 989.94 | 4.18% | 86 | 2.36% | 1.23% | 1.6 | 0.3 | 1.6% | 1 | Long | 65% | 2.5 | -1 |
| Long is the preferred trading strategy with 65% chance of being right. Both trend sentiment and hourly trend are very strong. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-05-21 17:01:36 Analysts speculate on the future stock valuation of Eli Lilly, with optimism tied to its performance in the weight-loss drug market. |
| 2026-05-21 17:01:36 Lower costs of Eli Lilly and Novo Nordisk's weight-loss medications are driving patient choices away from compounded drugs. |
| 2026-05-21 17:01:36 Eli Lilly's next-gen obesity drug is on track for regulatory approval, following successful trial results that could influence market entry. |
| 2026-05-21 17:01:36 The competitive landscape in the weight-loss drug market features Eli Lilly and Novo Nordisk, as well as emerging players like Viking Therapeutics. |
| 2026-05-21 17:01:36 Eli Lilly is developing next-generation weight-loss drugs that demonstrate significant results in clinical trials, contributing to advancements in obesity treatment. |
| 2026-05-21 13:48:50 Eli Lilly's stock experienced a rise following the announcement of successful trial results for the GLP-1 drug. |
| 2026-05-21 13:48:50 The development of Eli Lilly’s new GLP-1 drug shows promise in significantly aiding weight loss, signaling a breakthrough in obesity treatments. |
| 2026-05-21 11:50:16 A positive response in Eli Lilly's stock following the news of the drug's successful trial. |
| 2026-05-21 11:50:16 The effectiveness of Eli Lilly's GLP-1 drug in achieving significant weight loss over an extended period. |
| 2026-05-21 09:36:35 Eli Lilly's experimental obesity shot shows significant efficacy in weight loss, potentially rivaling traditional bariatric surgery. |
| 2026-05-21 09:36:35 The growing demand for weight loss drugs is set to impact multiple players in the market, indicating a strong trend towards obesity treatments. |